4.4 Article

Conventional renal cancer in a patient with fumarate hydratase mutation

期刊

HUMAN PATHOLOGY
卷 38, 期 5, 页码 793-796

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.humpath.2006.10.011

关键词

HLRCC; bilateral renal cell cancer; clear cell; fumarate hydratase; FH

向作者/读者索取更多资源

Hereditary Ieiomyomatosis and renal cell cancer (HLRCC) is a tumor predisposition syndrome caused by mutations in the fumarate hydratase (FH) gene. HLRCC is characterized by uterine and cutaneous leimyomas, renal cell cancer, and uterine leiomyosarcoma. Typically, renal cell cancers in HLRCC are unilateral and display a papillary type 2 or ductal histology. We describe here a 23-year-old patient carrying a novel FH mutation (N330S) with a bilateral renal cell cancer. Carcinoma of the right kidney showed papillary structure, but the left tumor was diagnosed as a conventional (clear cell) renal carcinoma, a type not previously described in HLRCC. The clear cell renal carcinoma also displayed loss of the normal FH allele and the FH immunostaining. Our finding extends the number of cases in which HLRCC can be suspected, and the FH immunohistochemistry may serve as a useful too] to screen for HLRCC in young individuals with clear cell renal carcinoma. (c) 2007 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据